The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,448,634 in first-year total cost, median $877,580.
Most frequent study sections
- HIV Immunopathogenesis and Vaccine Development Study Section[HIVD]5
- Special Emphasis Panel[ZRG1 IIDA-U (02)]2
- Special Emphasis Panel[ZRG1 DCAI-D (02)]1
- Special Emphasis Panel[ZRG1 IIDB-X (03)]1
Most frequent institutions
- EMORY UNIVERSITY3
- JOHNS HOPKINS UNIVERSITY1
- UNIVERSITY OF CALIFORNIA AT DAVIS1
- UNIVERSITY OF PENNSYLVANIA1
- UNIVERSITY OF TX MD ANDERSON CAN CTR1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Virus and Host Directed Immunotherapies for Cure in SHIV-infected Infant Macaques1R01AI192330-01 | CHAHROUDI, ANN M | EMORY UNIVERSITY, GA | $1,332,155 | ZRG1 |
| 2025 | Reversing effector-to-memory transition at ARTi to impact the HIV reservoir towards ART-free control1R01AI192331-01 | MARTINELLI, ELENAVILLINGER, FRANCOIS J | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $1,016,951 | ZRG1 |
| 2025 | IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV Remission1R01AI187162-01A1 | PODANY, ANTHONY TVELU, VIJAYAKUMARVILLINGER, FRANCOIS J | EMORY UNIVERSITY, GA | $800,389 | HIVD |
| 2024 | Targeting the HIV-1 reservoir at cART initiation with CD4-mimetic interventions1R01AI186809-01 | FINZI, ANDRESKUMAR, PRITISODROSKI, JOSEPH G | YALE UNIVERSITY, CT | $1,314,572 | HIVD |
| 2024 | IL-15 Therapy Combined with TGF-Beta Blockade for Sustained HIV Remission1R56AI187162-01 | PODANY, ANTHONY TVELU, VIJAYAKUMARVILLINGER, FRANCOIS J | EMORY UNIVERSITY, GA | $927,200 | HIVD |
| 2024 | Impact of Neonatal ART and Broadly Neutralizing Antibodies on HIV-1 Reservoirs in Infants: Towards ART-free Remission1R01AI186792-01 | PERSAUD, DEBORAH | JOHNS HOPKINS UNIVERSITY, MD | $877,580 | HIVD |
| 2024 | Modulation of Galectin-9 to Target HIV Persistence1R01AI184421-01A1 | NDHLOVU, LISHOMWA CPILLAI, SATISH KUMAR | VITALANT, AZ | $775,391 | ZRG1 |
| 2024 | Understanding reservoir effects and curative potential of a CD3/CCR5 bispecific antibody in infant macaques1R01AI184418-01A1 | HARTIGAN-O'CONNOR, DENNIS J. | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $710,095 | ZRG1 |
| 2024 | Early interventions at ART initiation to reduce the HIV-1 reservoir and enhance adaptive immune responses1R01AI184285-01A1 | BETTS, MICHAEL RJONES, BRAD RSØGAARD, OLE SCHMELTZ | UNIVERSITY OF PENNSYLVANIA, PA | $694,301 | HIVD |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.